NGM Biopharmaceuticals, Inc. Pre-Tax Profit Margin 2018-2023 | NGM
NGM Biopharmaceuticals, Inc. pre-tax profit margin from 2018 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Pre-Tax Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
2023-12-31 |
$0.00B |
$-0.14B |
-3575.00% |
2023-09-30 |
$0.02B |
$-0.15B |
-686.36% |
2023-06-30 |
$0.03B |
$-0.17B |
-582.76% |
2023-03-31 |
$0.04B |
$-0.18B |
-494.44% |
2022-12-31 |
$0.06B |
$-0.16B |
-294.55% |
2022-09-30 |
$0.06B |
$-0.15B |
-263.79% |
2022-06-30 |
$0.07B |
$-0.14B |
-195.65% |
2022-03-31 |
$0.08B |
$-0.13B |
-160.26% |
2021-12-31 |
$0.08B |
$-0.12B |
-153.16% |
2021-09-30 |
$0.08B |
$-0.12B |
-156.41% |
2021-06-30 |
$0.08B |
$-0.12B |
-150.00% |
2021-03-31 |
$0.09B |
$-0.11B |
-131.76% |
2020-12-31 |
$0.09B |
$-0.10B |
-118.39% |
2020-09-30 |
$0.10B |
$-0.09B |
-92.86% |
2020-06-30 |
$0.10B |
$-0.07B |
-74.23% |
2020-03-31 |
$0.10B |
$-0.05B |
-52.94% |
2019-12-31 |
$0.10B |
$-0.04B |
-41.35% |
2019-09-30 |
$0.12B |
$-0.01B |
-10.83% |
2019-06-30 |
$0.12B |
$-0.01B |
-8.40% |
2019-03-31 |
$0.12B |
$-0.01B |
-4.31% |
2018-12-31 |
$0.11B |
$-0.00B |
-0.92% |